Kiyosaki buys one Bitcoin at $67,000 amid volatility Author cites debt fears and dollar printing concerns Bitcoin struggles below $68,000 after failed breakout Kiyosaki buys one Bitcoin at $67,000 amid volatility Author cites debt fears and dollar printing concerns Bitcoin struggles below $68,000 after failed breakout

Robert Kiyosaki Buys Bitcoin at $67,000 as Price Struggles Below $68,000

2026/02/22 01:31
2 min read
  • Kiyosaki buys one Bitcoin at $67,000 amid volatility
  • Author cites debt fears and dollar printing concerns
  • Bitcoin struggles below $68,000 after failed breakout attempts

Prominent financial author Robert Kiyosaki has revealed a fresh Bitcoin purchase during the latest market pullback. According to a post he shared on X, the “Rich Dad Poor Dad” author bought one whole Bitcoin at approximately $67,000. His disclosure comes as the world’s largest cryptocurrency continues to trade below the $68,000 level. Bitcoin recently attempted twice to break above $68,000 but failed to hold that position. As a result, the asset remains in a consolidation phase. However, Kiyosaki signaled that short-term weakness did not alter his long-term outlook.


According to his statement, his decision rests on expectations of renewed money printing in the United States. He argued that mounting national debt could pressure the dollar and eventually force the Federal Reserve to expand the money supply. He described future liquidity injections as trillions of “fake dollars” entering the system.

Robert Kiyosaki Buys Bitcoin at $67,000 as Price Struggles Below $68,000

Moreover, Kiyosaki pointed to Bitcoin’s fixed supply as a central reason for his continued accumulation. The cryptocurrency has a hard cap of 21 million coins. More than 19 million coins have already been mined, leaving a limited amount still to be produced. Consequently, he emphasized that increasing scarcity strengthens Bitcoin’s long-term value proposition.


Also Read: Bitfinex Says Quantum Computing Risk to Bitcoin Remains Distant


Price Context and Broader Market Signals

Bitcoin hovered near $67,000 when Kiyosaki disclosed his purchase. Traders closely monitored resistance near $68,000 after repeated rejections in recent sessions. Additionally, volatility increased as market participants reacted to shifting macroeconomic signals.


Kiyosaki also referenced warnings from his 2013 book “Rich Dad’s Prophecy.” According to a separate post this week, he believes a major market crash is now imminent. He stated that positions in Bitcoin, Ethereum, gold and silver could benefit during financial turbulence. His latest purchase reinforces his consistent strategy of buying during market dips rather than rallies.


Also Read: Brad Garlinghouse Reacts as XRP Community Takes Spotlight at ETHDenver


The post Robert Kiyosaki Buys Bitcoin at $67,000 as Price Struggles Below $68,000 appeared first on 36Crypto.

Market Opportunity
The Official 67 Coin Logo
The Official 67 Coin Price(67)
$0.002682
$0.002682$0.002682
-9.57%
USD
The Official 67 Coin (67) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

        Highlights:  Inflows of altcoins in exchanges have surged by 22% in early 2026. An increase in deposits indicates a growing sell-side pressure. The 
Share
Coinstats2026/02/22 02:03